{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:26:09Z","timestamp":1772655969726,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ygyno.2020.06.484","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T09:06:54Z","timestamp":1593162414000},"page":"769-775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Derangements in HUWE1\/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma"],"prefix":"10.1016","volume":"158","author":[{"given":"Elena","family":"Bonazzoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Zammataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Gnutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pelligra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nupur","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Manara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Tymon-Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Zeybek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Altwerger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulden","family":"Menderes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanhee","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Arin","family":"Silasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaagn","family":"Andikyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Azodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro D.","family":"Santin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.06.484_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hoc.2011.11.005","article-title":"Management of cervical precancers: a global perspective","volume":"26","author":"Echelman","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0010","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2005.09.040","article-title":"HPV16\/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities","volume":"100","author":"Santin","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0020","doi-asserted-by":"crossref","first-page":"22730","DOI":"10.1073\/pnas.1911385116","article-title":"Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy","volume":"116","author":"Zammataro","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","author":"Cancer Genome Atlas Research N","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2020.06.484_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2005.03.037","article-title":"ARF-BP1\/mule is a critical mediator of the ARF tumor suppressor","volume":"121","author":"Chen","year":"2005","journal-title":"Cell."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0040","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1101\/gad.214577.113","article-title":"Mule\/Huwe1\/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc\/Miz1-mediated down-regulation of p21 and p15","volume":"27","author":"Inoue","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0045","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/sj.onc.1205817","article-title":"A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer","volume":"21","author":"Chen","year":"2002","journal-title":"Oncogene."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2005.08.016","article-title":"The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation","volume":"123","author":"Adhikary","year":"2005","journal-title":"Cell."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12038-016-9623-z","article-title":"Tumour suppressive function of HUWE1 in thyroid cancer","volume":"41","author":"Ma","year":"2016","journal-title":"J. Biosci."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.15252\/emmm.201606684","article-title":"HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation","volume":"9","author":"Myant","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-230X(10)07006-5","article-title":"MYC in oncogenesis and as a target for cancer therapies","volume":"107","author":"Albihn","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014217","article-title":"MYC, metabolism, cell growth, and tumorigenesis","volume":"3","author":"Dang","year":"2013","journal-title":"Cold. Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0075","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0095","doi-asserted-by":"crossref","first-page":"E4558","DOI":"10.1073\/pnas.1608319113","article-title":"Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms","volume":"113","author":"Shi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0100","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1158\/1078-0432.CCR-18-0864","article-title":"Inhibition of BET Bromodomain proteins with GS-5829 and GS-626510 in uterine serous carcinoma, a biologically aggressive variant of endometrial Cancer","volume":"24","author":"Bonazzoli","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2007.02.022","article-title":"Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases","volume":"26","author":"Hao","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygyno.2020.06.484_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2020.06.484_bb0115","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1158\/1541-7786.MCR-16-0346","article-title":"R1 regulates prostate tumor growth and progression by transcriptional suppression of the E3 ligase HUWE1 to stabilize c-Myc","volume":"16","author":"Lin","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0120","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/onc.2015.309","article-title":"Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival","volume":"35","author":"Fan","year":"2016","journal-title":"Oncogene."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ncb1727","article-title":"The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein","volume":"10","author":"Zhao","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2020.06.484_bb0130","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/bjc.2015.388","article-title":"PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2\/neu overexpressing uterine serous carcinomas","volume":"113","author":"Black","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.06.484_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2019.01.002","article-title":"PI3K oncogenic mutations mediate resistance to afatinib in HER2\/neu overexpressing gynecological cancers","volume":"153","author":"Bonazzoli","year":"2019","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582032299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582032299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:53:42Z","timestamp":1758772422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582032299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S009082582032299X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.484","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derangements in HUWE1\/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}